ISU ABXIS

ISU ABXIS is a biotechnology company dedicated to the development of new and novel biotherapeutics aimed at enhancing the lives and easing the suffering of patients struggling with rare diseases and cancers. With the goal of developing innovative antibody-based therapeutics, the name ABXIS reflects our dedication to becoming an axis of antibody (Ab) therapeutics. Our pipeline includes treatments for Gaucher Disease, Fabry Disease, and various cancers as we work towards becoming a leading biotechnology company in South Korea.